| Alexandra Carrick Atwood, MD | |
|
1635 Aurora Ct Fl 4, Aurora, CO 80045-2541 | |
| (720) 848-0000 | |
| Not Available |
| Full Name | Alexandra Carrick Atwood |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 9 Years |
| Location | 1635 Aurora Ct Fl 4, Aurora, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700273869 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | DR.0062513 (Colorado) | Secondary |
| 2084E0001X | Psychiatry & Neurology - Epilepsy | DR.0062513 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Colorado Hospital Authority | Aurora, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Physicians Incorporated | 3476465667 | 2657 |
News Archive
Amgen today announced that detailed results from two pivotal Phase 3 studies evaluating Vectibix® (panitumumab) in combination with chemotherapy for the first and second-line treatment of metastatic colorectal cancer (mCRC) (the PRIME '203' and '181' trials, respectively) will be presented at the 2010 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in Orlando, Florida from Jan. 22-24, 2010.
Children with both autism and attention deficit or attention deficit hyperactivity disorders are four times more likely to bully than children in the general population, according to a study released in the journal, Ambulatory Pediatrics.
Jon Tyson, M.D., M.P.H., the Michelle Bain Distinguished Professor of Medicine and Public Health at The University of Texas Health Science Center at Houston Medical School, has won the 2014 APGAR Award for his lifelong contributions to perinatal medicine and education.
In response to the release of Health Canada's Updated Assessment of Bisphenol A (BPA) Exposure from Food Sources, which found that that BPA is safe for use in food-contact materials, the American Chemistry Council (ACC) has issued the following statement: "Health Canada's announcement today once again confirms that BPA is safe for use in food-contact materials," said Steven G. Hentges, Ph.D. of ACC's Polycarbonate/BPA Global Group.
Anacor Pharmaceuticals announced today that it has completed enrollment in its Phase 2b trial of AN2728, a topical anti-inflammatory product candidate for the treatment of psoriasis. Psoriasis is a chronic inflammatory skin disease that affects approximately 7.5 million people in the United States and over 100 million people worldwide.
› Verified 5 days ago
| Entity Name | University Physicians Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962461889 PECOS PAC ID: 3476465667 Enrollment ID: O20031105000375 |
News Archive
Amgen today announced that detailed results from two pivotal Phase 3 studies evaluating Vectibix® (panitumumab) in combination with chemotherapy for the first and second-line treatment of metastatic colorectal cancer (mCRC) (the PRIME '203' and '181' trials, respectively) will be presented at the 2010 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in Orlando, Florida from Jan. 22-24, 2010.
Children with both autism and attention deficit or attention deficit hyperactivity disorders are four times more likely to bully than children in the general population, according to a study released in the journal, Ambulatory Pediatrics.
Jon Tyson, M.D., M.P.H., the Michelle Bain Distinguished Professor of Medicine and Public Health at The University of Texas Health Science Center at Houston Medical School, has won the 2014 APGAR Award for his lifelong contributions to perinatal medicine and education.
In response to the release of Health Canada's Updated Assessment of Bisphenol A (BPA) Exposure from Food Sources, which found that that BPA is safe for use in food-contact materials, the American Chemistry Council (ACC) has issued the following statement: "Health Canada's announcement today once again confirms that BPA is safe for use in food-contact materials," said Steven G. Hentges, Ph.D. of ACC's Polycarbonate/BPA Global Group.
Anacor Pharmaceuticals announced today that it has completed enrollment in its Phase 2b trial of AN2728, a topical anti-inflammatory product candidate for the treatment of psoriasis. Psoriasis is a chronic inflammatory skin disease that affects approximately 7.5 million people in the United States and over 100 million people worldwide.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alexandra Carrick Atwood, MD Po Box 110429, Aurora, CO 80042-0429 Ph: () - | Alexandra Carrick Atwood, MD 1635 Aurora Ct Fl 4, Aurora, CO 80045-2541 Ph: (720) 848-0000 |
News Archive
Amgen today announced that detailed results from two pivotal Phase 3 studies evaluating Vectibix® (panitumumab) in combination with chemotherapy for the first and second-line treatment of metastatic colorectal cancer (mCRC) (the PRIME '203' and '181' trials, respectively) will be presented at the 2010 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in Orlando, Florida from Jan. 22-24, 2010.
Children with both autism and attention deficit or attention deficit hyperactivity disorders are four times more likely to bully than children in the general population, according to a study released in the journal, Ambulatory Pediatrics.
Jon Tyson, M.D., M.P.H., the Michelle Bain Distinguished Professor of Medicine and Public Health at The University of Texas Health Science Center at Houston Medical School, has won the 2014 APGAR Award for his lifelong contributions to perinatal medicine and education.
In response to the release of Health Canada's Updated Assessment of Bisphenol A (BPA) Exposure from Food Sources, which found that that BPA is safe for use in food-contact materials, the American Chemistry Council (ACC) has issued the following statement: "Health Canada's announcement today once again confirms that BPA is safe for use in food-contact materials," said Steven G. Hentges, Ph.D. of ACC's Polycarbonate/BPA Global Group.
Anacor Pharmaceuticals announced today that it has completed enrollment in its Phase 2b trial of AN2728, a topical anti-inflammatory product candidate for the treatment of psoriasis. Psoriasis is a chronic inflammatory skin disease that affects approximately 7.5 million people in the United States and over 100 million people worldwide.
› Verified 5 days ago
Lea C Watson, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1890 N Revere Ct, Aurora, CO 80045 Phone: 720-848-0000 | |
Robert House, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Ann Olincy, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 | |
Paul Moe, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Dr. Erin Schwarz, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1537 Alton St, Aurora, CO 80010 Phone: 303-617-2300 | |
Robert Clyman, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234 | |
Dr. Bishara Bhasi, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000 |